Miss Mounira Kharoubi

University Hospital Henri Mondor, Creteil (France)

Follow

Contributor content

Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis

Presentation

Sequential cyclophosphamide-bortezomib-dexamethasone (CyBorD) unmasks the harmful cardiac effect of dexamethasone in primary (AL) cardiac amyloidosis

ESC 365 is supported by

novartis

Explore sponsored resources